Lactose Intolerance Treatment Market Size, Trends, Growth Drivers And Forecast To 2033

Overview and Scope

Lactose intolerance treatment is a treatment for a condition that causes symptoms in the digestive system. It is a digestive disorder in which enough lactase is not produced. This condition can cause abdominal pain, flatulence, bloating, cramps, acidity, and diarrhea. A natural enzyme (lactase) produced by the body is substituted in the treatment of lactose intolerance.

Sizing and Forecast

The lactose intolerance treatment market size has grown strongly in recent years. It will grow from $30.52 billion in 2023 to $32.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased awareness, changing dietary patterns, global rise in lactose intolerance cases, growing healthcare infrastructure, consumer preferences for natural and alternative products, government investments.

The lactose intolerance treatment market size is expected to see strong growth in the next few years. It will grow to $43.59 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continued research and development, increasing incidence rates, personalized medicine approaches, rising healthcare expenditure, globalization of dietary habits, patient-centric healthcare. Major trends in the forecast period include rising demand for dairy alternatives, technological advancements in diagnostic tools, development of enzyme supplements, nutraceuticals and functional foods, global awareness and education initiatives, expansion in emerging markets.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/lactose-intolerance-treatment-global-market-report

Segmentation & Regional Insights

The lactose intolerance treatment market covered in this report is segmented –

1) By Treatment: Food Supplements, Enzyme Lactase Supplements, Probiotics, Other Treatments

2) By Intolerance Type: Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance, Developmental Lactose Intolerance

3) By Route of Administration: Oral, Injectable

4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

North America was the largest region in the lactose intolerance treatment market in 2023. The regions covered in the lactose intolerance treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9478&type=smp

Major Driver Impacting Market Growth

The increasing incidences of small intestine diseases are expected to propel the growth of the lactose intolerance treatment market going forward. The small intestine disease affects the body’s digestive system and results in two conditions that are characterized by persistent gastrointestinal tract inflammation. Small intestine disorders are treated with lactose intolerance treatment. It contains lactose, which is broken down by the enzyme lactase into the simpler sugar glucose and galactose in the small intestine. For instance, in October 2022, according to a report by the United European Gastroenterology (UEG), an Austria-based non-profit organization, throughout Europe, more than 300 million people suffer from digestive illnesses. The cost of digestive diseases as a percentage of GDP was 0.12%, which translates to a potential cost of $20 billion in Europe in 2021, and the estimated cost of preventing productivity losses in 2019 was $11.4 billion. In the future, this will increase to $34.2 billion for 75% reductions. Therefore, increasing incidences of small intestine diseases are driving the growth of the lactose intolerance treatment market.

Key Industry Players

Major companies in the lactose intolerance treatment market are introducing innovative products, such as animal-free creams, to sustain their position in the market. Animal-free cream cheese is a dairy-free alternative made from plant-based ingredients, catering to individuals with lactose intolerance by providing a non-dairy option for those seeking a substitute for traditional cream cheese derived from animal milk. For instance, in February 2022, Modern Kitchen, a US-based animal-free products company, launched the world’s first animal-free cream cheese. It is made from precision fermentation technology in which DNA sequences of real dairy are encoded into microorganisms that produce proteins similar to real milk. The product is made from real dairy and is lactose-free, hormone-free, and cholesterol-free.

The lactose intolerance treatment market report table of contents includes:

Executive Summary
Lactose Intolerance Treatment Market Characteristics
Lactose Intolerance Treatment Market Trends And Strategies
Lactose Intolerance Treatment Market – Macro Economic Scenario
Global Lactose Intolerance Treatment Market Size and Growth
Lactose Intolerance Treatment Market Segmentation
Lactose Intolerance Treatment Market Regional And Country Analysis

………..

Key Mergers And Acquisitions In The Lactose Intolerance Treatment Market
Lactose Intolerance Treatment Market Future Outlook and Potential Analysis
Appendix

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Lactose Intolerance Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Lactose Intolerance Treatment Market, Segmentation By Intolerance Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Lactose Intolerance Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

……….

Table 75: Johnson & Johnson Services Inc. Financial Performance

Table 76: Abbott Laboratories Inc. Financial Performance

Table 77: Macleods Pharmaceuticals Limited Financial Performance

Table 78: Nature’s Way Brands LLC Financial Performance

Table 79: Profarma Financial Performance

Explore the trending research reports from TBRC:

https://goodprnews.com/ground-support-equipment-market-share/

https://topprnews.com/hemoglobin-a1c-testing-devices-market-trends/

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/